drugset / Trial / NCT02557581

cAMP Signaling and Muscle Adaptations

NCT02557581

Unknown 72 enrolled University of Copenhagen
RandomizedParallel-groupTriple-blindBasic science

Summary

The role of cAMP signaling mediated by beta2-adrenergic stimulation with agonists has been well-studied in skeletal muscles of animals. Studies in humans are scant and the scope of the present study is thus to investigate the role of cAMP signaling by beta2-adrenergic stimulation for muscle adaptations in humans.

Timeline

Start
2015-07
Primary completion
2017-06-30
Completion
2017-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Clenbuterol Small molecule
Subject Terbutaline Small molecule

Indications

No indication recorded.